CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

recurrent acute myeloid leukemia, recurrent chronic myelomonocytic leukemia, recurrent myelodysplastic syndrome, refractory acute myeloid leukemia, refractory chronic myelomonocytic leukemia, refractory mixed phenotype acute leukemia, refractory myelodysplastic syndrome, refractory acute leukemia of ambiguous lineage, refractory acute undifferentiated leukemia, interventional, phase1